Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?

Schilling C, Gilles M, Blum WF, Daseking E, Colla M, Weber-Hamann B, Lederbogen F, Krumm B, Heuser I, Wudy SA, Kopf D, Deuschle M.

J Clin Psychopharmacol. 2013 Feb;33(1):99-103. doi: 10.1097/JCP.0b013e31827cb179.

PMID:
23277262
2.

Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.

Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA; OPERATION Study Team.

J Clin Psychopharmacol. 2010 Aug;30(4):357-64. doi: 10.1097/JCP.0b013e3181e7784f.

PMID:
20571433
3.

Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.

Sterr A, Padberg F, Amann B, Mergl R, Mulert C, Juckel G, Hegerl U, Pogarell O.

J Clin Psychiatry. 2006 Feb;67(2):325-6. No abstract available.

PMID:
16566633
4.

Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine.

Kraus T, Haack M, Schuld A, Hinze-Selch D, Koethe D, Pollmächer T.

Pharmacopsychiatry. 2002 Nov;35(6):220-5.

PMID:
12518269
5.

Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.

Paslakis G, Luppa P, Gilles M, Kopf D, Hamann-Weber B, Lederbogen F, Deuschle M.

J Psychiatr Res. 2010 Jun;44(8):556-60. doi: 10.1016/j.jpsychires.2009.11.015. Epub 2009 Dec 21.

PMID:
20022345
7.

An overview of the clinical efficacy of mirtazapine.

Benkert O, Muller M, Szegedi A.

Hum Psychopharmacol. 2002 Jun;17 Suppl 1:S23-6. Review.

PMID:
12404666
8.

Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.

Hummel J, Westphal S, Weber-Hamann B, Gilles M, Lederbogen F, Angermeier T, Luley C, Deuschle M, Kopf D.

J Clin Psychiatry. 2011 Jul;72(7):885-91. doi: 10.4088/JCP.09m05853blu. Epub 2011 Jan 25.

PMID:
21294998
9.

A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.

Mazeh D, Shahal B, Aviv A, Zemishlani H, Barak Y.

Int Clin Psychopharmacol. 2007 Nov;22(6):371-5.

PMID:
17917556
10.

Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.

Scharnholz B, Weber-Hamann B, Lederbogen F, Schilling C, Gilles M, Onken V, Frankhauser P, Kopf D, Deuschle M.

Psychiatry Res. 2010 May 15;177(1-2):109-13. doi: 10.1016/j.psychres.2009.08.010. Epub 2010 Apr 8.

PMID:
20381159
11.

Effect of mirtazapine treatment on body composition and metabolism.

Laimer M, Kramer-Reinstadler K, Rauchenzauner M, Lechner-Schoner T, Strauss R, Engl J, Deisenhammer EA, Hinterhuber H, Patsch JR, Ebenbichler CF.

J Clin Psychiatry. 2006 Mar;67(3):421-4.

PMID:
16649829
12.

Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study.

Montgomery SA, Reimitz PE, Zivkov M.

Int Clin Psychopharmacol. 1998 Mar;13(2):63-73.

PMID:
9669186
13.

Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.

Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM Jr; Mirtazapine vs. Paroxetine Study Group.

Am J Geriatr Psychiatry. 2002 Sep-Oct;10(5):541-50.

PMID:
12213688
14.

Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?

Bateman DN, Chick J, Good AM, Kelly CA, Masterton G.

Eur J Clin Pharmacol. 2004 May;60(3):221-4. Epub 2004 Apr 9. Erratum in: Eur J Clin Pharmacol. 2005 Mar;61(1):73.

PMID:
15083251
15.

Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.

Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S; Mirtazapine-Venlafaxine Study Group.

J Clin Psychopharmacol. 2001 Aug;21(4):425-31.

PMID:
11476127
16.

Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial.

Han C, Pae CU, Lee BH, Ko YH, Masand PS, Patkar AA, Joe SH, Jung IK.

Clin Drug Investig. 2008;28(4):251-61.

PMID:
18345715
17.

Mirtazapine compared with paroxetine in major depression.

Benkert O, Szegedi A, Kohnen R.

J Clin Psychiatry. 2000 Sep;61(9):656-63.

PMID:
11030486
18.

Treatment with paroxetine, but not amitriptyline, lowers levels of lipoprotein(a) in patients with major depression.

Paslakis G, Kopf D, Westphal S, Gilles M, Lederbogen F, Hamann B, Heuser I, Deuschle M.

J Psychopharmacol. 2011 Oct;25(10):1344-6. doi: 10.1177/0269881110382469. Epub 2010 Oct 15.

PMID:
20952454
19.
20.

Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment.

Kopf D, Westphal S, Luley CW, Ritter S, Gilles M, Weber-Hamann B, Lederbogen F, Lehnert H, Henn FA, Heuser I, Deuschle M.

J Clin Psychopharmacol. 2004 Oct;24(5):527-31.

PMID:
15349009
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk